TransUnion (TRU) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-03-31..
- Stock-based compensation / revenue · 12 months: Value 3.23%; Formula and calculation Share-based compensation / revenue. Period ending 2026-03-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 3.23% | Share-based compensation / revenue. Period ending 2026-03-31. $152.80M ÷ $4.73B × 100 ≈ 3.23% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 4.73B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 152.80M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 848.20M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | (m) | $4.73B | $152.80M | $848.20M | (m) | (m) | 3.23% | (m) | (m) |
| 2025-12-31 | (m) | $4.58B | $145.60M | $857.80M | (m) | (m) | 3.18% | (m) | (m) |
| 2025-09-30 | (m) | $4.44B | $142.50M | $825.00M | (m) | (m) | 3.21% | (m) | (m) |
| 2025-06-30 | (m) | $4.36B | $139.90M | $773.70M | (m) | (m) | 3.21% | (m) | (m) |
| 2025-03-31 | (m) | $4.26B | $127.40M | $763.90M | (m) | (m) | 2.99% | (m) | (m) |
| 2024-12-31 | (m) | $4.18B | $121.20M | $666.70M | (m) | (m) | 2.90% | (m) | (m) |
| 2024-09-30 | (m) | $4.10B | $113.00M | $557.10M | (m) | (m) | 2.76% | (m) | (m) |
| 2024-06-30 | (m) | $3.98B | $106.20M | $164.50M | $280.30M | (m) | 2.66% | 0.59× | Reported |
| 2024-03-31 | (m) | $3.91B | $102.30M | $140.50M | $285.10M | (m) | 2.61% | 0.49× | Reported |
| 2023-12-31 | (m) | $3.83B | $100.30M | $128.50M | $288.20M | (m) | 2.62% | 0.45× | Reported |
| 2023-09-30 | (m) | $3.78B | $93.70M | $129.80M | $284.70M | (m) | 2.48% | 0.46× | Reported |
| 2023-06-30 | (m) | $3.75B | $86.40M | $616.70M | $273.20M | (m) | 2.30% | 2.26× | Reported |
| 2023-03-31 | (m) | $3.73B | $84.00M | $640.70M | $252.50M | (m) | 2.25% | 2.54× | Reported |
| 2022-12-31 | (m) | $3.71B | $82.80M | $630.50M | $230.90M | (m) | 2.23% | 2.73× | Reported |
| 2022-09-30 | (m) | $3.60B | $82.20M | $601.00M | $198.90M | (m) | 2.28% | 3.02× | Reported |
| 2022-06-30 | (m) | $3.40B | $78.80M | $601.10M | $163.30M | (m) | 2.32% | 3.68× | Reported |
| 2022-03-31 | (m) | $3.18B | $73.10M | $619.10M | $137.00M | (m) | 2.30% | 4.52× | Reported |
| 2021-12-31 | (m) | $2.96B | $69.20M | $647.70M | $112.60M | (m) | 2.34% | 5.75× | Reported |
| 2021-09-30 | (m) | $3.01B | $68.90M | $732.40M | $104.70M | (m) | 2.29% | 7.00× | Reported |
| 2021-06-30 | (m) | $2.91B | $60.00M | $705.40M | $106.60M | (m) | 2.06% | 6.62× | Reported |
| 2021-03-31 | (m) | $2.77B | $59.90M | $611.80M | $114.40M | (m) | 2.16% | 5.35× | Reported |
| 2020-12-31 | (m) | $2.72B | $46.90M | $567.90M | $126.30M | (m) | 1.73% | 4.50× | Reported |
| 2020-09-30 | (m) | $2.70B | $50.90M | $577.70M | $138.60M | (m) | 1.88% | 4.17× | Reported |
| 2020-06-30 | (m) | $2.70B | $55.90M | $586.70M | $154.50M | (m) | 2.07% | 3.80× | Reported |
| 2020-03-31 | (m) | $2.72B | $46.00M | $622.50M | $166.30M | (m) | 1.69% | 3.74× | Reported |
| 2019-12-31 | (m) | $2.66B | $51.00M | $607.80M | $173.60M | (m) | 1.92% | 3.50× | Reported |
| 2019-09-30 | (m) | $2.58B | $50.70M | $583.90M | $178.70M | (m) | 1.96% | 3.27× | Reported |
| 2019-06-30 | (m) | $2.50B | $53.20M | $534.70M | $179.20M | (m) | 2.13% | 2.98× | Reported |
| 2019-03-31 | (m) | $2.40B | $58.30M | $509.40M | $159.90M | (m) | 2.43% | 3.19× | Reported |
| 2018-12-31 | (m) | $2.32B | $57.90M | $512.50M | $137.50M | (m) | 2.50% | 3.73× | Reported |
| 2018-09-30 | (m) | (m) | $46.90M | $503.20M | $114.30M | (m) | (m) | 4.40× | Reported |
| 2018-06-30 | (m) | (m) | $38.50M | $507.70M | $92.00M | (m) | (m) | 5.52× | Reported |
| 2018-03-31 | (m) | (m) | $34.60M | $488.80M | $88.70M | (m) | (m) | 5.51× | Reported |
| 2017-12-31 | (m) | $1.93B | $33.10M | $464.70M | $87.60M | (m) | 1.71% | 5.30× | Reported |
| 2017-09-30 | (m) | (m) | $32.90M | $432.40M | $88.20M | (m) | (m) | 4.90× | Reported |
| 2017-06-30 | (m) | (m) | $31.40M | $401.70M | $87.90M | (m) | (m) | 4.57× | Reported |
| 2017-03-31 | (m) | (m) | $28.70M | $349.70M | $86.60M | (m) | (m) | 4.04× | Reported |
| 2016-12-31 | (m) | $1.70B | $24.40M | $300.50M | $85.50M | (m) | 1.43% | 3.51× | Reported |
| 2016-09-30 | (m) | (m) | $16.90M | $260.20M | $82.90M | (m) | (m) | 3.14× | Reported |
| 2016-06-30 | (m) | (m) | $12.70M | $224.60M | $86.30M | (m) | (m) | 2.60× | Reported |
| 2016-03-31 | (m) | (m) | $10.30M | $212.50M | $109.80M | (m) | (m) | 1.94× | Reported |
| 2015-12-31 | (m) | $1.51B | $9.00M | $197.10M | $134.20M | (m) | 0.60% | 1.47× | Reported |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $1.30B | $8.00M | $128.40M | $190.00M | (m) | 0.61% | 0.68× | Reported |
| 2014-09-30 | (m) | (m) | $7.80M | $144.20M | $194.90M | (m) | (m) | 0.74× | Reported |
| 2014-06-30 | (m) | (m) | $7.00M | $152.80M | $199.40M | (m) | (m) | 0.77× | Reported |
| 2014-03-31 | (m) | (m) | $6.40M | $159.80M | $198.60M | (m) | (m) | 0.80× | Reported |
| 2013-12-31 | (m) | $1.18B | $6.30M | $169.20M | $197.60M | (m) | 0.53% | 0.86× | Reported |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $1.17B | (m) | $188.40M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $1.06B | (m) | $185.40M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EQUIFAX INC (EFX) | United States | $17.483B | 26.99 |
| MOODYS CORP /DE/ (MCO) | United States | $80.966B | 28.07 |
| S&P Global Inc. (SPGI) | United States | $119.368B | 26.35 |